CN101375978A - Medicinal composition for lowering blood fat - Google Patents
Medicinal composition for lowering blood fat Download PDFInfo
- Publication number
- CN101375978A CN101375978A CNA2007101210543A CN200710121054A CN101375978A CN 101375978 A CN101375978 A CN 101375978A CN A2007101210543 A CNA2007101210543 A CN A2007101210543A CN 200710121054 A CN200710121054 A CN 200710121054A CN 101375978 A CN101375978 A CN 101375978A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- preparation
- piperis longi
- fructus piperis
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition with the effect of reducing blood lipid, which comprises Crataegus pinnatifida, Alisma orientalis, Polygonum cuspidatum, Piper longum and Rehmannia glutinosa. The preparation method of the composition comprises the following steps: extracting active ingredients from raw materials, mixing with a specified amount of one or more pharmaceutically acceptable medical adjuvants or excipients according to a certain proportion, and making into a desired dosage form. The composition with the effect of reducing blood lipid can distinctly reduce the contents of plasma cholesterol and low density cholesterol, and also can be used for preparing medicines and health foods for reducing blood lipid.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of Chinese medicine compound of being made up of Fructus Crataegi, Rhizoma Alismatis, Rhizoma Polygoni Cuspidati, Fructus Piperis Longi and Radix Rehmanniae Preparata, compound recipe of the present invention has the effect of blood fat reducing.
Background technology
Hyperlipemia belongs to commonly encountered diseases in clinical, with advancing age, its sickness rate also obviously increases, and is particularly common in obese people.Hyperlipemia plays an important role in arteriosclerosis, cause of coronary heart disease mechanism, causes people's common concern, the control of cardiovascular and cerebrovascular disease is brought in the government utility in China, puts on an equal footing with the infectious disease control.Over nearly 20 years, blood-fat regulating medicine is of a great variety, according to the difference of main therapeutical effect, roughly is divided into two big classes: to reduce the Statins that pushes away that blood T-CHOL and low density lipoprotein, LDL are main head, cut down his spit of fland as simvastatin, pravastatin and chlorine; Another kind of is based on triglyceride reducing, is representative with the special class of shellfish, and as fenofibrate and gemfibrozil etc., they are line medicines of control dyslipidemia, have the effect of high density lipoprotein increasing.Except that some chemical medicines, the Chinese patent medicine that is used for hyperlipidemia is also more, as SHANZHAJING JIANGZHI PIAN, extracts active component by Fructus Crataegi and makes, and is used for the interior card that stagnates of the food stasis of blood of hyperlipidemia; But the fat clearing capsule is made up of Semen Lepidii, Radix Scutellariae, Fructus Crataegi, Radix Et Rhizoma Rhei, Rhizoma Alismatis, the Radix Aucklandiae, is used for accumulateing disease in the phlegm-damp of hyperlipidemia; The Yunnan pollen tianqi oral liquid is made up of pollen of Semen Fagopyri Esculenti, Typhonium flagelliforme (Lodd.) Blume, Mel, is used for the syndrome of static blood blocking collaterals of hyperlipemia, class this also have a lot.Publication aspect, CN1263772A discloses a kind of capsule for descend of blood fat, it is made up of Fructus Crataegi, the Radix Polygoni Multiflori, Rhizoma Alismatis, Radix Bupleuri, Radix Salviae Miltiorrhizae, Pericarpium Citri Reticulatae, Semen Raphani, Radix Curcumae, has that strengthening spleen, tonifying kidney is soothing the liver, a promoting blood circulation to remove stagnancy blood stasis dispelling effect treatment fatty liver, and the hyperlipemia effect is better; CN1364512A discloses a kind of defatting and poison expelling capsule, selects Radix Et Rhizoma Rhei, the Radix Polygoni Multiflori, Semen Cassiae, Rhizoma Alismatis for use, through ethanol extraction, Fructus Gardeniae, Radix Bupleuri, Rhizoma Curcumae, Fructus Crataegi, Herba Artemisiae Scopariae water are carried, make capsule, it can treat and prevent hyperlipemia, blood fat reducing, elimination hemorheology obstacle.CN1283288C discloses a kind of preparation method of capsule for descend of blood fat, this capsule is to be prepared from by Radix Puerariae, Fructus Crataegi, Rhizoma Alismatis, Radix Polygoni Multiflori and Radix Angelicae Sinensis, have promoting digestion and removing stagnation, blood circulation promoting and blood stasis dispelling, strengthening spleen, tonifying kidney, clearing away heat-damp and promoting diuresis effect, be used for the treatment of hyperlipidemia, can reach the effect for the treatment of both the principal and the secondary aspects of a disease at the same time.
Summary of the invention
The object of the present invention is to provide a kind of blood fat reducing Chinese medicine composition of determined curative effect.
Another object of the present invention also is to provide a kind of method for preparing this blood fat reducing Chinese medicine composition active component.
Blood fat reducing Chinese medicine composition of the present invention is that crude drug is formed by following weight portion: Fructus Crataegi 8-30 weight portion, Rhizoma Alismatis 5-14 weight portion, Rhizoma Polygoni Cuspidati 1-10 weight portion, Fructus Piperis Longi 1-10 weight portion, Radix Rehmanniae Preparata 1-10 weight portion; Be preferably Fructus Crataegi 10-20 weight portion, Rhizoma Alismatis 8-12 weight portion, Rhizoma Polygoni Cuspidati 5-10 weight portion, Fructus Piperis Longi 5-10 weight portion, Radix Rehmanniae Preparata 5-10 weight portion, Fructus Crataegi 15 weight portions more preferably, Rhizoma Alismatis 10 weight portions, Rhizoma Polygoni Cuspidati 8 weight portions, Fructus Piperis Longi 6 weight portions, Radix Rehmanniae Preparata 6 weight portions.
Among the present invention, Fructus Crataegi can be a haw berry, also can be Folium Crataegi, and haw berry is strong than the Fructus Crataegi effect with Fructus Crataegi (parched).Radix Rehmanniae is selected Radix Rehmanniae Preparata for use.
Among the we, Fructus Crataegi has the effect of promoting digestion and removing stagnation, invigorating the spleen and regulating the stomach, blood circulation promoting and blood stasis dispelling, is monarch drug in the side; Rhizoma Alismatis is apt to the promoting diuresis to eliminate damp pathogen heat clearing away, is ministerial drug in the side, assists monarch drug, makes its blood stasis dispelling blood and does not go up fresh blood, and dissipating depression of QI gas and do not hinder healthy energy makes heresy that outlet be arranged, jointly at primary symptom; Assistant is with Rhizoma Polygoni Cuspidati promoting blood circulation to remove blood stasis, dispelling wind and removing obstruction in the collateral, clearing away heat-damp and promoting diuresis, and Fructus Piperis Longi warming spleen and stomach for dispelling cold, therapeutic method to keep the adverse QI flowing downwards pain relieving remove vomiting, eliminate the phlegm and the dyspepsia that disappears with the warming the spleen stomach, thereby assists the promoting blood circulation to remove blood stasis of monarch drug, the merit of promoting digestion and removing stagnation; Make with Radix Rehmanniae Preparata, the YIN nourishing of can enriching blood, beneficial essence are filled out marrow, and promoting tissue regeneration by removing blood stasis makes blood fortune unimpeded.More than all medicines share, reinforcing and reducing are also executed, the effect that row stagnates and to promote blood circulation is played in treating both the principal and the secondary aspects of a disease at the same time altogether.
In the prescription of the present invention, each single medicinal material can be through respectively behind physical pulverization, merging mixing and be used as medicine with the medicinal powder form, also can merge after extracting each crude drug effective ingredient and be used as medicine, can also be to be used as medicine with other medicine dried cream powder form after extracting after the part medicine is pulverized again.When extracting each crude drug active component, crude drug can merge through decocting and boils or ethanol extraction, also can be to extract respectively separately to remerge behind the effective ingredient.
Blood fat reducing Chinese medicine composition active component of the present invention adds pharmaceutic adjuvant acceptable and excipient in the suitable pharmacy, can be prepared into various needed pharmaceutical dosage forms.Among the present invention, the drug prepared dosage form is preferably peroral dosage form, as tablet, capsule, granule, oral liquid, electuary, pill, powder, suspension, drop pill etc., more preferably capsule.
Be ground into fine powder as raw material of Chinese medicine of the present invention, merge evenly, pack powder.
After raw material of Chinese medicine of the present invention, water decoct, be condensed into relative density and be 1.15 concentrated solution, add an amount of correctives and antiseptic, make syrup or mixed-blood liquid.
Raw material of Chinese medicine of the present invention is directly pulverized the encapsulated capsule that gets in back; Or raw material of Chinese medicine of the present invention is behind effective component extracting, and effective ingredient is directly pulverized, in the hard capsule case of packing into, capsule; Or the active component of the present invention after extracting, joining in the fused Polyethylene Glycol, mixing splashes in the refrigerative liquid paraffin, can be made into drop pill.
Blood fat reducing Chinese medicine composition compound recipe extracts active ingredients of the present invention can realize in the following way:
Take by weighing each crude drug by weight, standby.
Rhizoma Alismatis powder is broken into coarse powder, soak with ethanol, respectively with the alcohol reflux three times of 10,8,8 times of amount 70%-95%, each 1.5 hours, filter, merge ethanol extract, be evaporated to the extractum shape, Rhizoma Alismatis extractum extract I.
Fructus Piperis Longi powder is broken into coarse powder, measures distilled water immersions with 12 times and spends the night, and extracts Fructus Piperis Longi volatile oil with steam distillation, collects the profit phase, leaves standstill the back and separates oil phase, and oil phase gets Fructus Piperis Longi volatile oil with anhydrous sodium sulfate dehydration, and is standby.
Fructus Crataegi, Rhizoma Polygoni Cuspidati, Radix Rehmanniae Preparata are soaked, and add the Fructus Piperis Longi after extracting volatile oil, with the water boiling and extraction of 10 times of amounts 3 times, merge water boiling and extraction liquid, concentrating under reduced pressure, extractum II.
Extractum I and extractum II are merged, mixing, drying is pulverized, and gets compositions extract dried cream powder.
Dried cream is made soft material with 75% ethanol, and granulation is sieved, drying, granulate, evenly spray Fructus Piperis Longi volatile oil after, add suitable pharmaceutical aids and excipient, make required preparation.
The present composition proves through pharmacological experiment study, can reduce the serum total cholesterol (TC) of experimental hyperlipemia rat and rabbit and the content of triglyceride (TG), change hyperlipemia rat hemorheology form, reduce its blood viscosity, and high density lipoprotein increasing that can be suitable (HDL-C) level, have significantly effect for reducing blood fat, can be used for preparing blood lipid-lowering medicine and health food.
Specific embodiment
Preparation embodiment
Below further specify technical scheme of the present invention from the preparation of activity extract of the present invention
Embodiment 1
Take by weighing following raw materials in weight: Fructus Crataegi 1500g, Rhizoma Alismatis 1000g, Rhizoma Polygoni Cuspidati 800g, Fructus Piperis Longi 600g, Radix Rehmanniae Preparata 600g, standby;
Rhizoma Alismatis powder is broken into coarse powder, and 85% ethanol soaks into, and 8 times of amount solvent refluxings extract 3 times, and each 1.5 hours, filter, merge ethanol extract, concentrating under reduced pressure gets concentrated solution I;
Fructus Piperis Longi is pulverized, and water is dipped to, and extracts Fructus Piperis Longi volatile oil with vapor distillation, collects Fructus Piperis Longi volatile oil, and is standby;
With Fructus Crataegi, Rhizoma Polygoni Cuspidati, Radix Rehmanniae Preparata pulverizing medicinal materials, merge, to soak, the Fructus Piperis Longi medicinal residues behind the volatile oil are extracted in adding, decoct to extract 3 times, each 1.5 hours, merge decocting liquid, concentrating under reduced pressure gets concentrated solution II;
Merge concentrated solution I, II, mixing, vacuum drying is pulverized, and sieves, and gets the activity extract powder;
The activity extract powder is made soft material with 75% ethanol, granulate, drying is sieved, drying, and granulate, the volatile oil that extraction is obtained sprays in the whole good granule, and mixing in No. 1 capsule of packing into, promptly gets capsule; Add additive of tablet, tabletting can get tablet; Perhaps directly pack gets granule.
Embodiment 2
Take by weighing following raw materials in weight: Fructus Crataegi 3000g, Rhizoma Alismatis 800g, Rhizoma Polygoni Cuspidati 500g, Fructus Piperis Longi 500g, Radix Rehmanniae Preparata 500g, standby;
Preparation process is with embodiment 1
Embodiment 3
Take by weighing following raw materials in weight: Fructus Crataegi 800g, Rhizoma Alismatis 1200g, Rhizoma Polygoni Cuspidati 500g, Fructus Piperis Longi 500g, Radix Rehmanniae Preparata 500g, standby;
Preparation process is with embodiment 1
Embodiment 4
Take by weighing following raw materials in weight: Fructus Crataegi 2000g, Rhizoma Alismatis 1000g, Rhizoma Polygoni Cuspidati 1000g, Fructus Piperis Longi 1000g, Radix Rehmanniae Preparata 1000g, standby;
Preparation process is with embodiment 1
Embodiment 5
Take by weighing following raw materials in weight: Fructus Crataegi 2500g, Rhizoma Alismatis 1100g, Rhizoma Polygoni Cuspidati 900g, Fructus Piperis Longi 700g, Radix Rehmanniae Preparata 700g, standby;
Preparation process is with embodiment 1
Pharmacology embodiment
Below from the pharmacology embodiment of the present composition beneficial effect of the present invention is described.In following examples, serving as the experiment medicine with the extract active component of embodiment 1 gained, but not merely be the active component that is limited to this ratio gained, only is in order to save space, beneficial effect of the present invention to be described at this.
1, to the influence of experimental hyperlipemia rat blood fat
(1) animal and grouping: laboratory animal, 40 of male Waster rats were for 6 ages in week, available from Beijing University's medical college Experimental Animal Center.After experimental rat given normal feedstuff and raise 7 days in advance, anesthetized rat, external jugular vein blood drawing 3mL detects the blood fat of every group of rat before the treatment respectively, press the TC level, animal is divided at random blank group, matched group, the present invention are heavy dose ofly organized, small dose group.
(2) preparation of experiment medicine: high lipid food: by normal feedstuff 78.8%, Adeps Sus domestica 10%, cholesterol 1%, yolk powder 10%, cholate 0.2% is formed; Extract of the present invention: the heavy dose of group of rat is irritated stomach every day and is given 4.8g/kg dosage for Coming-of-Age Day 15 times of consumption; Small dose group is Coming-of-Age Day 3.75 times of consumption, day not give 1.2g/kg dosage, irritates stomach 2mL; Blank group and matched group all give isopyknic normal saline.
(3) experimental technique: blank group gives normal feedstuff, and matched group gives high lipid food, and heavy dose of group, small dose group give high lipid food, and irritate stomach extract medicinal liquid of the present invention simultaneously, and continuous 25 days, whole filling stomach process was smooth, no abnormal reaction.The filling stomach is given the rat fasting and is weighed after 25 days, fasting second day through postcava blood drawing 5mL, detects blood fat and the hemorheology value of every group of rat respectively.
(4) experimental result: to the influence of rat fat, see Table 1～3, by the table result as can be known, give high lipid food after, model group and blank group relatively, Serum TC (T-CHOL), TG (triglyceride) level obviously increase, and show that high blood lipid model sets up; To the influence of hemorheology of rat, see Table 4, the result shows, model group and blank group relatively, the hemorheology of rat height cut viscosity, in cut viscosity, lowly cut viscosity and significantly increase, show that the high blood lipid model viscosity increases.
The influence of table 1 couple rat fat TC (x ± s, n=10)
Compare with the blank group,
#P＜0.01; Compare with model group,
*P＜0.05,
*P＜0.01
The influence of table 2 couple rat fat TG (x ± s, n=10)
Compare with the blank group,
#P＜0.01; Compare with model group,
*P＜0.05
The influence of table 3 couple rat fat HDL-C (x ± s, n=10)
The influence of table 4 pair hemorheology of rat (x ± s, n=10)
Compare with the blank group,
#P＜0.05,
##P＜0.01; Compare with model group,
*P＜0.05,
*P＜0.01
Respectively show the result as can be known from last, the large and small dosage group of the present invention all can significantly reduce Serum TC, TG level (P＜0.05 or P＜0.01), to the influence of rat HDL-C level, there was no significant difference.From hemorheological angle, the present composition can large and small dosage group all can significantly reduce the rat blood height cut viscosity and in cut viscosity (P＜0.05 or P＜0.01), heavy dose of group can significantly reduce to hang down cuts viscosity (P＜0.01), but small dose group is to the low no significance of viscosity influence of cutting of rat blood.
2, to the influence of experimental rabbit blood fat
Get 20 of rabbit, the male and female dual-purpose, body weight 1.85 ± 0.27kg is divided into 4 groups at random, 5 every group, is divided into: normal control group, feed normal feedstuff; High fat matched group: feed high lipid food; High dose present composition group, the feed high lipid food, per kilogram of body weight is irritated stomach extract 4.8g of the present invention simultaneously; Low dosage extract group of the present invention, the feed high lipid food, per kilogram of body weight is irritated stomach extract 1.2g of the present invention simultaneously.High lipid food is formed the same.The animal sub-cage rearing, behind 14 days, 28 days after the administration, respectively by ear edge vein exploitating blood, separation of serum is measured serum total cholesterol TC, triglyceride TG, observes each group and changes.Experimental result shows, behind oral present composition 14d of rabbit and the 18d, hyperlipidemia model matched group group is compared serum total cholesterol content and content of triglyceride with the normal control group have significant difference (P＜0.01), give the extract of the present invention of various dose, compare with high fat matched group, all can reduce the content of serum total cholesterol and triglyceride, difference has significance (P＜0.01).Experimental result sees Table 5
Table 5 present composition to the influence of rabbit blood fat (x ± s, n=5)
Compare with normal control,,
##P＜0.01; Compare with model control group,
*P＜0.01
Claims (10)
1, a kind of pharmaceutical composition of blood fat reducing is characterized in that being made up of following bulk drugs: Fructus Crataegi 8-30 weight portion, Rhizoma Alismatis 5-14 weight portion, Rhizoma Polygoni Cuspidati 1-10 weight portion, Fructus Piperis Longi 1-10 weight portion, Radix Rehmanniae Preparata 1-10 weight portion.
2, pharmaceutical composition as claimed in claim 1 is characterized in that being made up of following bulk drugs: Fructus Crataegi 10-20 weight portion, Rhizoma Alismatis 8-12 weight portion, Rhizoma Polygoni Cuspidati 5-10 weight portion, Fructus Piperis Longi 5-10 weight portion, Radix Rehmanniae Preparata 5-10 weight portion.
3, pharmaceutical composition as claimed in claim 2 is characterized in that being made up of following bulk drugs: Fructus Crataegi 15 weight portions, Rhizoma Alismatis 10 weight portions, Rhizoma Polygoni Cuspidati 8 weight portions, Fructus Piperis Longi 6 weight portions, Radix Rehmanniae Preparata 6 weight portions.
4, a kind of is the pharmaceutical preparation that main active is made by claim 1,2 or 3 described pharmaceutical compositions.
5, preparation as claimed in claim 4 is characterized in that described preparation is an oral formulations.
6, preparation as claimed in claim 5 is characterized in that described oral formulations is mainly tablet, capsule, granule, oral liquid, electuary, pill, powder, suspension, drop pill.
7, preparation as claimed in claim 6 is characterized in that capsule.
8, preparation is characterized in that comprising the steps: as the method for claim 1,2 or 3 described pharmaceutical composition active component
(1) take by weighing medical material by weight, standby;
(2) Rhizoma Alismatis powder is broken into coarse powder, soak with ethanol, and reflux, extract, 3 times, merge extractive liquid,, concentrating under reduced pressure gets Rhizoma Alismatis extractum I;
(3) Fructus Piperis Longi is dipped to water, and steam distillation extracts Fructus Piperis Longi volatile oil, collects oil content, and is standby;
(4) Fructus Crataegi, Rhizoma Polygoni Cuspidati, the Radix Rehmanniae Preparata decoction pieces, suitably pulverizing merges, and soaks, and adds the Fructus Piperis Longi that has extracted volatile oil, decocts 3 times, filters, and merges decoction liquor, and concentrating under reduced pressure gets concentrated solution II;
(5) merge concentrated solution, drying gets the dried cream of active component;
(6) dried cream powder is broken, sieve, make soft material with 75% ethanol, the granulation of sieving, drying, granulate sprays Fructus Piperis Longi volatile oil, and mixing is made preparation.
9, method as claimed in claim 8 is wherein extracted the ethanol that used ethanol is 70%-95%.
10, have the medicine of effect for reducing blood fat and the application in the health food as claim 1,2 or 3 described compositionss in preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101210543A CN101375978B (en) | 2007-08-29 | 2007-08-29 | Medicinal composition for lowering blood fat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101210543A CN101375978B (en) | 2007-08-29 | 2007-08-29 | Medicinal composition for lowering blood fat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101375978A true CN101375978A (en) | 2009-03-04 |
| CN101375978B CN101375978B (en) | 2012-08-22 |
Family
ID=40419824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101210543A Active CN101375978B (en) | 2007-08-29 | 2007-08-29 | Medicinal composition for lowering blood fat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101375978B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103251746A (en) * | 2013-05-21 | 2013-08-21 | 翟纯杉 | Traditional Chinese medicine composition for reducing blood sugar and invigorating kidney and strengthening yang |
| CN103372072A (en) * | 2012-04-17 | 2013-10-30 | 常福厚 | Compound mixture with antihyperlipidemic effect and preparation method thereof |
| CN104056023A (en) * | 2013-03-22 | 2014-09-24 | 曹昌银 | Traditional Chinese medicine health care composition for reducing blood lipid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1159047C (en) * | 2002-01-18 | 2004-07-28 | 北京大学 | Active components of Chinese-medicinal medicine with weight-losing and hypolipemic actions and its relative medicine |
| CN100484408C (en) * | 2006-11-24 | 2009-05-06 | 朱迅 | A fat-reducing health tea and preparation method thereof |
-
2007
- 2007-08-29 CN CN2007101210543A patent/CN101375978B/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103372072A (en) * | 2012-04-17 | 2013-10-30 | 常福厚 | Compound mixture with antihyperlipidemic effect and preparation method thereof |
| CN104056023A (en) * | 2013-03-22 | 2014-09-24 | 曹昌银 | Traditional Chinese medicine health care composition for reducing blood lipid |
| CN103251746A (en) * | 2013-05-21 | 2013-08-21 | 翟纯杉 | Traditional Chinese medicine composition for reducing blood sugar and invigorating kidney and strengthening yang |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101375978B (en) | 2012-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006060951A1 (en) | A pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof | |
| CN101612362B (en) | Complex preparation for regulating lipid and preventing and curing heart cerebrovascular diseases and preparation method thereof | |
| CN104083727A (en) | Traditional Chinese medicine composition for nourishing and protecting liver | |
| CN103386022B (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN102475830B (en) | Medicinal composition for treating coronary disease and angina pectoris, preparation method thereof and preparation thereof | |
| CN103372051B (en) | Red rice and kudzuvine root medicinal composition for regulating blood fat and preparation method of the composition | |
| CN101485870A (en) | Medicament for promoting digestion and expelling intestinal parasites | |
| CN101023982B (en) | Medicine composition for treating osteoporosis | |
| CN101375978B (en) | Medicinal composition for lowering blood fat | |
| CN101933973B (en) | Medicament composition for preventing and treating liver damage | |
| CN102784248A (en) | Chinese medicine composition for preventing and treating alcoholic liver injury | |
| CN1263503C (en) | 'Changyuan' capsule and preparing techniue | |
| CN101485722B (en) | Medicament composition containing drynaria and salvia root, and use thereof | |
| CN101579405B (en) | Traditional Chinese medicine for curing constipation and preparation method thereof | |
| CN100518765C (en) | A compound Chinese medicinal preparation | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| KR101864719B1 (en) | Composition for prevention and treatment of osteoporosis comprising the extract of medicinal herb mixture | |
| CN102335255B (en) | Chinese medicine for treating hyperlipidemia and fatty liver and preparation method thereof | |
| CN101390970A (en) | Traditional Chinese medicine for treating hepatitis B and preparation method thereof | |
| CN103372040B (en) | Monas cuspurpureus Went Rhizoma Chuanxiong drug regimen of a kind of adjusting blood lipid and preparation method thereof | |
| CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof | |
| CN101112432A (en) | Fatty liver treating Chinese medicine and method for preparing the same | |
| CN1839931B (en) | Medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN104056234A (en) | Drug for dispelling alcohol effect and preparing method thereof | |
| CN103372114B (en) | Red rice and rhizoma alismatis medicinal composition for regulating blood fat and preparation method of composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |